Castleark Management’s ICU Medical ICUI Stock Holding History

Castleark Management’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-34,695	Closed	-$9.81M	–	385
2018 Q3	$9.81M	Sell	34,695 -34,645	-50%	-$10.1M	0.28%	117
2018 Q2	$20.4M	Sell	69,340 -1,972	-3%	-$539K	0.63%	35
2018 Q1	$18M	Buy	71,312 +20,202	+40%	+$4.75M	0.57%	41
2017 Q4	$11M	Buy	51,110 +49,470	+3,016%	+$10M	0.33%	105
2017 Q3	$305K	Hold	1,640	–	–	0.01%	345
2017 Q2	$283K	Buy	+1,640	New	+$263K	0.01%	347
2017 Q1	–	Sell	-55,055	Closed	-$8.11M	–	388
2016 Q4	$8.11M	Buy	+55,055	New	+$7.97M	0.26%	137
2016 Q1	–	Sell	-72,735	Closed	-$8.2M	–	388
2015 Q4	$8.2M	Buy	72,735 +100	+0.1%	+$11.1K	0.25%	104
2015 Q3	$7.95M	Sell	72,635 -3,680	-5%	-$394K	0.26%	105
2015 Q2	$7.3M	Buy	+76,315	New	+$7.13M	0.2%	146

Other funds holding ICUI

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Castleark Management's ICUI Position: Q4 2018 in Review

Castleark Management sold out of ICU Medical (ICUI) in Q4 2018, closing a stake of 34,695 shares — an estimated $9.81M sold.

Castleark Management first reported a position in ICUI in Q2 2015 and held it in 10 quarters. The position peaked at $20.4M in Q2 2018. 294 funds tracked by Wall St. Rank hold ICUI as of Q4 2018.

Castleark Management reported no remaining ICU Medical position as of Q4 2018 after selling out during the quarter.
Castleark Management sold 34,695 ICU Medical shares in Q4 2018, an estimated $9.81M.
Castleark Management first reported a position in ICU Medical in Q2 2015 and held it in 10 quarters.
Castleark Management's ICU Medical position peaked at $20.4M in Q2 2018.
294 funds tracked by Wall St. Rank held ICU Medical as of Q4 2018.

Based on Castleark Management's 13F filing for Q4 2018, filed 12 Feb 2019.